Mylan (MYL) agrees to brief House Committee next week - Bloomberg
- Japan's Nikkei posts biggest point gain for fiscal year
- Citi downgrades tech stocks as its flagship indicator signals 'euphoria' levels
- UBS sees 5 warnings signals on semiconductor chip stocks
- 2 reasons why Tesla stock fell on Thursday
- US consumer sentiment tops estimates in March to hit nearly 3-yr high, UMich says
- AMC Entertainment (AMC) enters into an equity distribution agreement
- Kerrisdale Capital is short Microstrategy (MSTR), long bitcoin
- AMC Entertainment (AMC) Enters $250M ATM Agreement
- Intuitive Machines (LUNR) Files for $300M Share Offering, 160M Share Offering by Selling Stockholders
- Home Depot (HD) to Acquire SRS Distribution for $18.25B EV
Mylan (MYL) Weakness on Headlines it May Have Misclassified EpiPen Under Medicaid
September 2, 2016 12:11 PM EDTMylan (NASDAQ: MYL) weaker on headlines it may have misclassified EpiPen under medicaid, according to lawmakers - Bloomberg. Shares down 3.1%.
... MoreMylan (MYL) Denies Rumors CEO Bresch to Step Down
September 2, 2016 10:43 AM EDTEmbattled EpiPen maker Mylan (NASDAQ: MYL), in an email to StreetInsider, denied rumors that its CEO Heather Bresch will step down. Comments were in response to earlier speculation following a DealReporter story.
A Mylan spokesperson also told StreetInsider that it pulled out... More
Mylan (MYL) Pulled from Morgan Stanley Conference Due to Scheduling Conflict - Spokesperson
September 2, 2016 9:59 AM EDTA Mylan (NASDAQ: MYL) spokesperson said the company pulled from an upcoming Morgan Stanley conference due to a scheduling conflict,
... MoreRumors Abound on Mylan (MYL) After Conference Cancellation
September 2, 2016 9:48 AM EDTThere are a lot of rumors floating around Mylan (NASDAQ: MYL) after the company was said to pull form a Morgan Stanley conference. One rumors is the CEO is going to leave.
Shares are down 2.2% early following Hillary Clinton outline on curbing drug price hikes.
... More